News
We look at the continued turmoil within the FDA, including the forced dismissal of top gene therapy regulator Nicole Verdun, ...
The death of a boy with Duchenne muscular dystrophy, tied to a gene therapy, is above all a tragedy. But it is also ...
The Alliance for Regenerative Medicine has voiced deep disappointment about reports that the FDA has put the director of its ...
AbbVie, Lilly, Roche and Takeda have demonstrated strong interest in licensing innovator oligonucleotides for CNS indications ...
19h
Investor's Business Daily on MSNHow IBD 50's Hims & Hers Is Shaking Up The Weight-Loss BrawlIn the battle for weight-loss supremacy, Hims & Hers Health has emerged as a dark horse candidate shaking up the market.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results